Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.

Home
/
Records
/
Untitled Letter
/
LeeSar, Inc.

UNTITLED LETTER

•LeeSar, Inc.•June 17, 2022

FDA UNTITLED_LETTER - LeeSar, Inc. - June 17, 2022

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Record Details

This UNTITLED LETTER record concerns LeeSar, Inc., with an inspection on June 17, 2022, covering drugs.

Company: LeeSar, Inc.
Inspection Date: June 17, 2022
Product Type: Drugs
Person: José R. Lopez (Program Expert)

Open in Dashboard

ID · a3af623c-849a-4645-8cdf-1e4dd1cafbe2

Global Key Solutions

Regulatory Data Transformed

Contact

New York Office:

370 Jay Street 7th Floor

Brooklyn, NY 11201

Scranton Office:

Scranton Enterprise Center, Suite 217

201 Lackawanna Avenue

Scranton, PA, 18503

🇺🇸+1 917-789-5099

🇪🇺+48 532-447-507

info@globalkeysolutions.net

Quick Links

KeyPedia™ Lite

Legal & Ethics

©2026, Global Key Solutions All rights reserved.

FDA UNTITLED_LETTER - LeeSar, Inc. - June 17, 2022 | Global Key Solutions